The European Narcolepsy Network (EU-NN) database

Archive ouverte

Khatami, Ramin | Luca, Gianina | Baumann, Christian | Bassetti, Claudio | Bruni, Oliviero | Canellas, Francesca | Dauvilliers, Yves, M | del Rio-Villegas, Rafael | Feketeova, Eva | Ferri, Raffaele | Geisler, Peter | Högl, Birgit | Jennum, Poul, J | Kornum, Birgitte, M | Lecendreux, Michel | Martins-Da-Silva, Antonio | Mathis, Johannes | Mayer, Geert | Paiva, Teresa | Partinen, Markku | Peraita-Adrados, Rosa | Plazzi, Guiseppe | Santamaria, Joan | Sonka, Karel | Riha, Renata | Tafti, Mehdi | Wierzbicka, Aleksandra | Young, Peter, J.W. | Lammers, Gert Jan | Overeem, Sebastiaan | Network, European Narcolepsy

Edité par CCSD ; Wiley -

International audience. Narcolepsy with cataplexy is a rare disease with an estimated prevalence of 0.02% in European populations. Narcolepsy shares many features of rare disorders, in particular the lack of awareness of the disease with serious consequences for healthcare supply. Similar to other rare diseases, only a few European countries have registered narcolepsy cases in databases of the International Classification of Diseases or in registries of the European health authorities. A promising approach to identify disease-specific adverse health effects and needs in healthcare delivery in the field of rare diseases is to establish a distributed expert network. A first and important step is to create a database that allows collection, storage and dissemination of data on narcolepsy in a comprehensive and systematic way. Here, the first prospective web-based European narcolepsy database hosted by the European Narcolepsy Network is introduced. The database structure, standardization of data acquisition and quality control procedures are described, and an overview provided of the first 1079 patients from 18 European specialized centres. Due to its standardization this continuously increasing data pool is most promising to provide a better insight into many unsolved aspects of narcolepsy and related disorders, including clear phenotype characterization of subtypes of narcolepsy, more precise epidemiological data and knowledge on the natural history of narcolepsy, expectations about treatment effects, identification of post-marketing medication side-effects, and will contribute to improve clinical trial designs and provide facilities to further develop phase III trials.

Consulter en ligne

Suggestions

Du même auteur

New 2013 incidence peak in childhood narcolepsy: more than vaccination?

Archive ouverte | Zhang, Zhongxing | CCSD

International audience. Abstract Increased incidence rates of narcolepsy type-1 (NT1) have been reported worldwide after the 2009–2010 H1N1 influenza pandemic (pH1N1). While some European countries found an associat...

Exploring the clinical features of narcolepsy type 1 versus narcolepsy type 2 from European Narcolepsy Network database with machine learning

Archive ouverte | Zhang, Zhongxing | CCSD

International audience. Narcolepsy is a rare life-long disease that exists in two forms, narcolepsy type-1 (NT1) or type-2 (NT2), but only NT1 is accepted as clearly defined entity. Both types of narcolepsies belong...

Narcolepsy risk loci outline role of T cell autoimmunity and infectious triggers in narcolepsy

Archive ouverte | Ollila, Hanna, M | CCSD

International audience. Abstract Narcolepsy type 1 (NT1) is caused by a loss of hypocretin/orexin transmission. Risk factors include pandemic 2009 H1N1 influenza A infection and immunization with Pandemrix®. Here, w...

Chargement des enrichissements...